What is Celldex Therapeutics's change in AP?

Celldex Therapeutics (CLDX) reported change in AP of -$287K in Q1 2026.

How has Celldex Therapeutics's change in AP changed year-over-year?

Celldex Therapeutics's change in AP increased by 96.7% year-over-year, from -$8.72M to -$287K.

What is the long-term trend for Celldex Therapeutics's change in AP?

Over 4 years (2021 to 2025), Celldex Therapeutics's change in AP has grown at a 31.8% compound annual growth rate (CAGR), from $3.65M to $11.03M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

Celldex Therapeutics CLDX Change in AP

Change in AP at other companies

Eli LillyLLY

$2.55B+290%

PfizerPFE

-$117.25M+54.2%

Rogers CorporationROG

$8.1M+92.9%

AmgenAMGN

$571M+14.9%

Regeneron PharmaceuticalsREGN

$107.7M+150%

IncyteINCY

$23.45M+1,186%

Other financials

Income statement

See full

Revenue$15.0K-97.8%

Operating income-$84.4M-34.6%

Net income-$78.7M-46.3%

EPS (diluted)-$1.18-45.7%

Balance sheet

See full

Cash & equivalents$35.7M+109%

Total debt$1.9M-44.3%

Total equity$456.2M-35.1%

Total assets$511.3M-30.9%

Cash flow

See full

Operating cash flow-$65.6M-20.6%

CapEx$1.6M+518%

Free cash flow-$67.2M-23.0%

Valuation

See full

Market cap$2.59B+75.2%

Enterprise value$2.55B+74.4%

P/S2,989.2×+2,794×

Profitability

See full

Operating margin-35,688.5%-39,114pp

Net margin-32,753.6%-35,519pp

FCF margin-26,125.8%-28,907pp

Returns & leverage

See full

Return on equity-48.9%-498pp

Debt / equity0×0.0×

Current ratio8.9×-12.7×

Where this comes from

Reported directly by Celldex Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.

The official record: Celldex Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celldex Therapeutics's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Celldex Therapeutics's change in AP?: Celldex Therapeutics (CLDX) reported change in AP of -$287K in Q1 2026.
How has Celldex Therapeutics's change in AP changed year-over-year?: Celldex Therapeutics's change in AP increased by 96.7% year-over-year, from -$8.72M to -$287K.
What is the long-term trend for Celldex Therapeutics's change in AP?: Over 4 years (2021 to 2025), Celldex Therapeutics's change in AP has grown at a 31.8% compound annual growth rate (CAGR), from $3.65M to $11.03M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.